Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2025-12-24 @ 2:24 PM
NCT ID:
NCT04750759
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients in the age of 18 to 70 years
* Having a recent positive direct test for Sars-CoV-2
* Having mild or moderate COVID-19 symptoms with no indication for hospitalization due to SARS-CoV-2 infection (WHO Ordinal Scale 1-2)
Exclusion Criteria:
* Severe respiratory symptoms related to COVID-19 requiring oxygen or intensive care (high flow oxygen or mechanical ventilation or ECMO)
* Patients with preexisting pulmonary diseases requiring oxygen supply
* Patients with history of hypersensitivity to Camostat or Niclosamide or to any ingredients to any of the two drugs
* Patients with heart failure (NYHA III or NYHA IV)
* Patients with proven malignant tumor
* Patients diagnosed with influenza infection
* Pregnancy or breastfeeding
* Immunocompromised patients
* Creatinine clearance \< 60 mL/min
* aspartate aminotransferase (AST) / alanine aminotransferase (ALT) \> 2 times upper limit of normal (ULN)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT04750759
Study Brief:
Protocol Section:
NCT04750759